logo
Plus   Neg
Share
Email

Sun Pharma Launches Ezallor Sprinkle Capsules In U.S. For Difficulty Swallowing

Sun Pharmaceutical Industries Ltd. (SUNPHARMA,524715) announced Monday the U.S. launch of Ezallor Sprinkle (rosuvastatin) capsules for people who have difficulty swallowing.

Ezallor Sprinkle is formulated as extended-release-coated pellets that may be sprinkled over soft food such as applesauce, can be swallowed whole, or administered via a nasogastric tube to facilitate long-term, once-daily administration.

Sun Pharma said it is the first and only FDA-approved sprinkle formulation of rosuvastatin.

It is the second product in the Sun Pharma portfolio designed for individuals in long-term care.

The capsules are indicated for the treatment of three types of elevated lipid disorders in conjunction with diet in adults. These include to treat hypertriglyceridemia, primary dysbetalipoproteinemia, and as an adjunct to other lipid-lowering treatments or as monotherapy if such treatments are unavailable to reduce LDL-C, total cholesterol, and ApoB in adult patients with homozygous familial hypercholesterolemia.

The company noted that Ezallor Sprinkle has not been studied in Fredrickson type I and V dyslipidemias.

Chris Chappel, certified Medical Director, Chappel Senior Care and Chappel Group Research, said, "The risk of medication errors increases when people have difficulty swallowing, due to crushing of medicines that shouldn't be crushed, or from residual medication left over in crushing devices. This formulation will help in administering medication for patients with common types of elevated lipid disorders, especially in the geriatric population."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the third quarter on Thursday, branded food company Hormel Foods Corp. (HRL) reaffirms its earnings guidance for the full-year 2019, while trimming annual net sales outlook as its navigates near-term uncertainty related to African swine fever. For fiscal 2019,... The U.S. Food and Drug Administration has issued a warning letter to Ningbo Huize Commodity Co., an over-the-counter drug manufacturer, for significant current good manufacturing practice violations, including data integrity issues. The warning letter issued to Ningbo Huize details a failure to have... Crate and Barrel have recalled 1,500 push walkers due to risk of choking and laceration. Crate and Barrel have recalled Activity Push Walkers as those walkers can be damaged over time exposing sharp points and small parts, posing choking and laceration hazards to small children. The wooden recalled...
Follow RTT